Literature DB >> 12938522

Preparation of adriamycin magnetic albumin microspheres and their experimental antitumor effects in vitro and in vivo.

K Tao1, D Chen, J Chen, Y Tian, Z Wu, X Wang, X Yang.   

Abstract

The adriamycin magnetic microspheres (ADM-MAMs) were prepared by the heat-stabilized protein methods. Their physico-chemical properties were examined; their cytotoxicities against tumor cells in vitro were assayed by a modified MTT method, and their effects were observed on the implanted gastric tumor in Wistar rats given ADM-MAMs via alimentary canal at the presence of the external magnetic fields. The results showed that the ADM-MAMs were successfully prepared and had cytotoxic effect on tumor cells in vitro similar to the free ADM (P > 0.05). The inhibitory effects of ADM-MAMs on the implanted gastric tumor in vivo were significantly increased as compared with the controls (P < 0.01). Our results suggested that ADM-MAMs were a new type of adriamycin (ADM) preparation and its form alteration did not affect its anticancer effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12938522     DOI: 10.1007/bf02886967

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  6 in total

Review 1.  Drug targeting in cancer chemotherapy: a clinical perspective.

Authors:  P K Gupta
Journal:  J Pharm Sci       Date:  1990-11       Impact factor: 3.534

2.  Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.

Authors:  K Shimomura; T Manda; S Mukumoto; K Masuda; T Nakamura; T Mizota; S Matsumoto; F Nishigaki; T Oku; J Mori
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

3.  The identification of drug resistance in ovarian cancer and breast cancer: application of the MTT assay.

Authors:  J Sargent; A Elgie; C G Taylor; J Wilson; P Alton; J G Hill
Journal:  Contrib Gynecol Obstet       Date:  1994

4.  Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat.

Authors:  J M Gallo; P K Gupta; C T Hung; D G Perrier
Journal:  J Pharm Sci       Date:  1989-03       Impact factor: 3.534

5.  Chemotherapy of human carcinoma xenografts during pulsed magnetic field exposure.

Authors:  C J Hannan; Y Liang; J D Allison; C G Pantazis; J R Searle
Journal:  Anticancer Res       Date:  1994 Jul-Aug       Impact factor: 2.480

6.  In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres.

Authors:  K J Widder; A E Senyei; D F Ranney
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.